DVL1 and neoplasm: Rhodamine-tagged heptapeptide protein transduction domain for binding DVL (RHPDs) are small interfering peptides that disrupt the binding of FZD7 and the PDZ domain of DVL and were able to inhibit tumor growth in a mouse model of hepatocellular carcinoma (HCC) [244].